Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Bone Marrow Transplantation
|
April 12, 2011
Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike
I Danylesko, A Shimoni, A Nagler
Current Oncology Reports
|
December 21, 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect
A Shimoni, S Giralt, I Khouri, et al.
Bone Marrow Transplantation
|
March 3, 2015
G-CSF-primed BM for allogeneic SCT: revisited
I Pessach, I Resnick, A Shimoni, et al.
Bone Marrow Transplantation
|
February 27, 2001
Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation
A Shimoni, M Körbling, R Champlin, et al.
International Journal of Cardiology
|
March 24, 1995
Effect of dipyridamole on myocardial perfusion and function using technetium-99m MIBI
N Zafrir, R Bassevitch, A Shimoni, et al.
Bone Marrow Transplantation
|
October 8, 2013
Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT
R Shouval, O Bondi, H Mishan, et al.
Infection
|
April 29, 2010
Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience
M Yeshurun, A Gafter-Gvili, M Thaler, et al.
Bone Marrow Transplantation
|
August 4, 2015
Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
R Yerushalmi, N Shem-Tov, I Danylesko, et al.
Bone Marrow Transplantation
|
February 14, 2012
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity
A Shimoni, N Shem-Tov, Y Volchek, et al.
Blood
|
March 15, 1997
A model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: evidence for tumor-mediated suppression of antibody production in low-stage disease
A Shimoni, H Marcus, A Canaan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Bone Marrow Transplantation
|
April 12, 2011
Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike
I Danylesko, A Shimoni, A Nagler
Current Oncology Reports
|
December 21, 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect
A Shimoni, S Giralt, I Khouri, et al.
Bone Marrow Transplantation
|
March 3, 2015
G-CSF-primed BM for allogeneic SCT: revisited
I Pessach, I Resnick, A Shimoni, et al.
Bone Marrow Transplantation
|
February 27, 2001
Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation
A Shimoni, M Körbling, R Champlin, et al.
International Journal of Cardiology
|
March 24, 1995
Effect of dipyridamole on myocardial perfusion and function using technetium-99m MIBI
N Zafrir, R Bassevitch, A Shimoni, et al.
Bone Marrow Transplantation
|
October 8, 2013
Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT
R Shouval, O Bondi, H Mishan, et al.
Infection
|
April 29, 2010
Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience
M Yeshurun, A Gafter-Gvili, M Thaler, et al.
Bone Marrow Transplantation
|
August 4, 2015
Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
R Yerushalmi, N Shem-Tov, I Danylesko, et al.
Bone Marrow Transplantation
|
February 14, 2012
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity
A Shimoni, N Shem-Tov, Y Volchek, et al.
Blood
|
March 15, 1997
A model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: evidence for tumor-mediated suppression of antibody production in low-stage disease
A Shimoni, H Marcus, A Canaan, et al.
Page
of 4